DJ US Home Construction Ishares (ITB) 27.85 $ITB 5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Home Construction Ishares (ITB) 27.85 $ITB

5 Sector Favorites for Q3 Earnings & Their Hot ETFs
Sweta Killa - Zacks Investment Research - Thu Oct 08, 10:10AM CDT
These sector ETFs are expected to be the winners this earnings season.
DHI: 30.65 (unch), JNJ: 95.37 (+0.29), LEN: 51.33 (+0.26), JPM: 61.93 (-0.20), PFE: 33.24 (+0.15), ITB: 27.85 (-0.03), CARZ: 36.26 (+0.16), WFC: 52.14 (-0.40), BRK.B: 133.03 (-0.72), XLF: 23.24 (-0.15), IYT: 148.36 (+1.15), XLV: 68.44 (+0.31)

Don’t Count on Homebuilders, Regional Banks to Bail Out the Recovery
at The Street - Fri Oct 02, 4:55AM CDT
You can trade the volatility of housing and banking industries using three exchange-traded funds, but these are not for the long-term investor.
QABA: 38.95 (-0.38), ITB: 27.85 (-0.03), IAT: 34.26 (-0.38)

SmarTrend Watching for Potential Rebound in Shares of iShares Dow Jones US Homenstruction Index Fund After 1.68% Loss
Comtex SmarTrend(R) - Tue Sep 29, 4:11PM CDT
iShares Dow Jones US Homenstruction Index Fund (NYSE:ITB) traded in a range yesterday that spanned from a low of $25.50 to a high of $26.33. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $25.93 on volume of 9.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ITB: 27.85 (-0.03)

Biotechnology and Home Construction: 2 ETFs to Watch on Outsized Volume
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 8:01AM CDT
IBB and ITB saw massive trading volume in Monday's trading session
VRX: 175.94 (+4.77), SPY: 201.33 (+0.12), QQQ: 106.53 (+0.48), ITB: 27.85 (-0.03), DIA: 170.76 (+0.39), IBB: 308.45 (+1.25)

Two Homebuilder ETFs & Stocks Set to Soar
Sweta Killa - Zacks Investment Research - Mon Sep 28, 9:29AM CDT
Given the encouraging fundamentals and optimistic outlook, homebuilding stocks and ETFs will continue to surge and lead the market higher in Q4.
DHI: 30.65 (unch), LEN: 51.33 (+0.26), XHB: 36.33 (-0.02), ITB: 27.85 (-0.03)

Interesting ITB Put And Call Options For November 6th
DividendChannel.com - Thu Sep 24, 10:53AM CDT
Investors in iShares Dow Jones US Home Construction Index Fund saw new options begin trading today, for the November 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ITB options chain for the new November...
ITB: 27.85 (-0.03)

These 4 ETFs Are Crushing the Stock Market
Dan Caplinger, The Motley Fool - Motley Fool - Tue Sep 22, 7:40AM CDT
Russia has made a comeback in 2015. Image source: Wikimedia Commons. Exchange-traded funds have made it easier than ever to invest in the broad market or in particular niches within it. Yet many ETFs have taken big hits in 2015, as the stock market...
XBI: 64.76 (+1.11), ITB: 27.85 (-0.03), IBB: 308.45 (+1.25), RSX: 17.27 (-0.01)

iShares Dow Jones US Homenstruction Index Fund Set to Possibly Rebound After Yesterday's Selloff of 1.03%
Comtex SmarTrend(R) - Mon Sep 21, 4:32PM CDT
iShares Dow Jones US Homenstruction Index Fund (NYSE:ITB) traded in a range yesterday that spanned from a low of $27.67 to a high of $28.53. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $27.99 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ITB: 27.85 (-0.03)

Homebuilding on Sustained Growth: ETFs in Focus
Sweta Killa - Zacks Investment Research - Fri Sep 18, 8:40AM CDT
Home building recovery is still on the way despite the the disappointing housing starts data.
XLB: 44.15 (-0.02), SPY: 201.33 (+0.12), PKB: 24.29 (+0.06), XHB: 36.33 (-0.02), NAIL: 31.59 (+1.09), ITB: 27.85 (-0.03), HBU: 19.58 (+0.53)

'Fast Money' Recap: What to Buy After the Fed Did Nothing
at The Street - Fri Sep 18, 4:00AM CDT
The trading panel discussed, banks, utilities, homebuilders and whether Apple is dead money.
AMZN: 539.80 (+6.64), SPY: 201.33 (+0.12), SWKS: 79.50 (+0.07), XHB: 36.33 (-0.02), FB: 93.24 (+0.77), ITB: 27.85 (-0.03), XLI: 53.38 (+0.18), NXPI: 87.32 (+0.83), XLU: 43.79 (-0.21), INTC: 32.14 (-0.38), AAPL: 112.12 (+2.62)

Traders Debate Whether to Buy or Sell Stocks Ahead of Fed's Rate Decision
at The Street - Tue Sep 15, 1:48PM CDT
The CNBC 'Fast Money' traders made the case that a rate hike could spur a rally in stocks and that it's unlikely to cool the red-hot housing sector.
MLM: 165.07 (+2.01), DHI: 30.65 (unch), SPY: 201.33 (+0.12), XHB: 36.33 (-0.02), ITB: 27.85 (-0.03), EXP: 72.14 (-3.60), LPX: 17.38 (+0.43), AOS: 70.75 (-0.84)

Forget the Fed! These Stocks Are Jumping No Matter What…
Greg Guenthner - Daily Reckoning - Tue Sep 15, 9:08AM CDT
This post Forget the Fed! These Stocks Are Jumping No Matter What… appeared first on Daily Reckoning . Over the past three months, the iShares Dow Jones U.S. Home Construction ETF (NYSE:ITB) is up nearly 5%. Sure, the homebuilder ETF...
ITB: 27.85 (-0.03)

ITB January 2018 Options Begin Trading
StockOptionsChannel.com - Mon Sep 14, 10:12AM CDT
Investors in iShares Dow Jones US Home Construction Index Fund saw new options begin trading today, for the January 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858...
ITB: 27.85 (-0.03)

BUYINS.NET: TPX, WYNN, VIA, VBR, SE, ITB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 10, 6:46AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Tempur Pedic International Inc (NYSE:TPX), Wynn Resorts Ltd (NASDAQ:WYNN), Viacom Inc (NASDAQ:VIA), Vanguard Small Cap Value ETF (NYSE:VBR), SPECTRA ENERGY CORP (NYSE:SE), iShares Dow Jones US Home Construction Index Fund (NYSE:ITB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
VIA: 49.41 (-0.31), SE: 29.85 (-0.53), TPX: 77.11 (+1.25), VBR: 102.99 (-0.02), ITB: 27.85 (-0.03), WYNN: 75.40 (-0.51), VIAB: 47.48 (-0.44)

Watch for iShares Dow Jones US Homenstruction Index Fund to Potentially Pullback After Gaining 1.15% Yesterday
Comtex SmarTrend(R) - Thu Sep 03, 4:25PM CDT
iShares Dow Jones US Homenstruction Index Fund (NYSE:ITB) traded in a range yesterday that spanned from a low of $27.74 to a high of $28.23. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $27.97 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ITB: 27.85 (-0.03)

Summer Madness to Nut Case? A Fall Preview of ETFs
Sweta Killa - Zacks Investment Research - Thu Sep 03, 9:59AM CDT
The stock market went berserk in summer with performances swinging from sky-high in certain sectors to dreadful by others.
USO: 15.99 (-0.05), CNXT: 36.50 (-0.14), XHB: 36.33 (-0.02), FCG: 7.23 (-0.13), CARZ: 36.26 (+0.16), OIL: 9.30 (-0.02), ITB: 27.85 (-0.03), PSCE: 20.52 (-0.09), ASHS: 38.60 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading